Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Usana Health Sciences (USNA) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Usana Health Sciences (USNA) over the last 15 years, with Q3 2025 value amounting to $49000.0.

  • Usana Health Sciences' Interest Expenses changed 0.0% to $49000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $848000.0, marking a year-over-year increase of 18552.19%. This contributed to the annual value of $281000.0 for FY2024, which is 725.19% up from last year.
  • Latest data reveals that Usana Health Sciences reported Interest Expenses of $49000.0 as of Q3 2025, which was down 0.0% from $259000.0 recorded in Q2 2025.
  • In the past 5 years, Usana Health Sciences' Interest Expenses ranged from a high of $411000.0 in Q1 2025 and a low of -$1.6 million during Q1 2022
  • Moreover, its 5-year median value for Interest Expenses was $43000.0 (2023), whereas its average is -$3421.1.
  • In the last 5 years, Usana Health Sciences' Interest Expenses plummeted by 9869.28% in 2021 and then surged by 69038.46% in 2025.
  • Quarter analysis of 5 years shows Usana Health Sciences' Interest Expenses stood at $18000.0 in 2021, then soared by 77.78% to $32000.0 in 2022, then surged by 353.12% to $145000.0 in 2023, then decreased by 11.03% to $129000.0 in 2024, then plummeted by 62.02% to $49000.0 in 2025.
  • Its Interest Expenses was $49000.0 in Q3 2025, compared to $259000.0 in Q2 2025 and $411000.0 in Q1 2025.